
Audio By Carbonatix
A chemical found in curry is to be tested for its ability to kill bowel cancer tumours in patients.Curcumin, which is found in the spice turmeric, has been linked to a range of health benefits.Studies have already shown that it can beat cancer cells grown in a laboratory and benefits have been suggested in stroke and dementia patients as well.Now a trial at hospitals in Leicester will investigating giving curcumin alongside chemotherapy drugs.About 40,000 people are diagnosed with bowel cancer in the UK each year.If the disease spreads around the body, patients are normally given a combination of three chemotherapy drugs, but about half will not respond.Forty patients at Leicester Royal Infirmary and Leicester General Hospital will take part in the trial, which will compare the effects of giving curcumin pills seven days before starting standard chemotherapy treatment.'Difficult to treat'Prof William Steward, who is leading the study, said animal tests combining the two were "100 times better" than either on their own and that had been the "major justification for cracking on" with the trial.He said: "Once bowel cancer has spread it is very difficult to treat, partly because the side effects of chemotherapy can limit how long patients can have treatment."The prospect that curcumin might increase the sensitivity of cancer cells to chemotherapy is exciting because it could mean giving lower doses, so patients have fewer side effects and can keep having treatment for longer."This research is at a very early stage, but investigating the potential of plant chemicals to treat cancer is an intriguing area that we hope could provide clues to developing new drugs in the future."Joanna Reynolds, from Cancer Research UK, said: "By doing a clinical trial like this, we will find out more about the potential benefits of taking large amounts of curcumin, as well as any possible side effects this could have for cancer patients."
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Tags:
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
VIP Transport defends fare increase over rising fuel and maintenance costs
14 minutes -
LGBTQ+ issues not a priority for Ghanaians – Felix Kwakye Ofosu
29 minutes -
Kwakye Ofosu rejects NPP Minority’s call for apology over anti-LGBTQ bill
36 minutes -
Music giant Universal gets $64bn takeover offer
48 minutes -
NPP criticism of anti-LGBTQ Bill ‘nothing more than political posturing’ — Kwakye Ofosu
56 minutes -
Joy FM was birthed over a bowl of fufu’ – Tommy Annan-Forson shares interesting story
1 hour -
World Athletics to introduce standalone World Marathon Championships from 2030
1 hour -
Africa’s voice in global journalism grows as funding, AI and misinformation shape newsrooms
1 hour -
First Atlantic Bank holds Annual General Meeting, reports strong growth and bold outlook for 2026
1 hour -
Ghanaian-founded fintech WeWire secures Canadian PSP license to bridge African, global payments
1 hour -
Uganda confirms 2027 AFCON dates
1 hour -
40 convicted in Northern Region crime crackdown
1 hour -
‘We’re days away from parts of the world experiencing actual shortages:’ Eric Nuttall on energy
2 hours -
‘I’m Obroni in every country’ – Coco Blasian on music, survival and making Accra home
2 hours -
IMANI wants NIC to probe possible conflicts of interest in reinsurance arrangements
2 hours